Ocular toxicity of Anandron in patients treated for prostatic cancer.
暂无分享,去创建一个
[1] F. Labrie,et al. COMBINED TREATMENT WITH LHRH AGONIST AND PURE ANTIANDROGEN IN ADVANCED CARCINOMA OF PROSTATE , 1984, The Lancet.
[2] S. E. Simonsen,et al. OSCILLATORY POTENTIAL AND NYCTOMETRY IN INSULIN‐DEPENDENT DIABETICS , 1980, Acta ophthalmologica.
[3] R. Knighton,et al. The photostress recovery test in the clinical assessment of visual function. , 1977, American journal of ophthalmology.
[4] Resnick Mi,et al. Treatment of stage IV carcinoma of the prostate. , 1975 .
[5] K. Brown,et al. The electroretinogram: its components and their origins. , 1968, UCLA forum in medical sciences.
[6] H. Forsius,et al. THE DAZZLING TEST IN DISEASES OF THE RETINA , 1964, Acta ophthalmologica.
[7] F. Labrie,et al. Complete androgen blockade for the treatment of prostate cancer. , 1985, Important advances in oncology.
[8] M. Resnick,et al. Treatment of stage IV carcinoma of the prostate. , 1975, The Urologic clinics of North America.
[9] R. L. Tour,et al. Macular function and the photostress test 1. , 1967, Archives of ophthalmology.